AGL

agilon health, inc. (AGL) Management Analysis (2026)

Invetso Score: 2.4/10 — Weak · Last Updated: 2026-08-01

Overall Score

Management Quality

Management is operating with negative TTM margins and returns, including net profit margin of -4.24% and ROE of -119.35%.

Cash generation remains weak with negative operating cash flow and free cash flow, while interest coverage is deeply negative at -79.13x.

Balance-sheet leverage is not the main issue, but low profitability and poor capital efficiency limit confidence in execution.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on agilon health, inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →